↓ Skip to main content

Role of emmprin in endometrial cancer

Overview of attention for article published in BMC Cancer, May 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Role of emmprin in endometrial cancer
Published in
BMC Cancer, May 2012
DOI 10.1186/1471-2407-12-191
Pubmed ID
Authors

Keiichiro Nakamura, Junichi Kodama, Atsushi Hongo, Yuji Hiramatsu

Abstract

Extracellular matrix metalloproteinase inducer (Emmprin/CD147) is a transmembrane glycoprotein that belongs to the immunoglobulin superfamily. Enriched on the surface of many tumor cells, emmprin promotes tumor growth, invasion, metastasis and angiogenesis. We evaluated the clinical importance of emmprin and investigated its role in endometrial cancer.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Hong Kong 1 5%
Unknown 18 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 32%
Student > Ph. D. Student 4 21%
Student > Master 3 16%
Other 1 5%
Student > Bachelor 1 5%
Other 1 5%
Unknown 3 16%
Readers by discipline Count As %
Medicine and Dentistry 8 42%
Agricultural and Biological Sciences 5 26%
Engineering 1 5%
Unknown 5 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2012.
All research outputs
#4,193,186
of 5,034,930 outputs
Outputs from BMC Cancer
#2,234
of 2,817 outputs
Outputs of similar age
#63,904
of 78,201 outputs
Outputs of similar age from BMC Cancer
#55
of 70 outputs
Altmetric has tracked 5,034,930 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,817 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 78,201 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.